Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Evaluating the role of electro-mechanical integration of human pluripotent stem cell-derived cardiomyocyte graft in the treatment of myocardial infarction

EF 2019-20

Résumé
"Heart disease is the leading cause of death worldwide. Because the human heart has a limited capacity to regenerate, stem cell-based therapies have emerged as exciting treatment avenues. We can generate new cardiac cells from stem cells that mediate an improvement in heart function when injected after a heart attack in animal models. It is unclear, however, whether this improvement is due to new, functionally integrated heart muscle or due to indirect effects such as the release of growth factors or improved heart geometry. This mechanistic uncertainty remains a source of controversy in the field, and hampers progress towards clinical trials (as it, for example, remains unclear what cell dose, type and delivery mode are ideal). This project aims to investigate the roles of the direct and indirect mechanisms underpinning the improved heart function observed after injecting new cardiac cells into an infarct scar. First, we will genetically engineer stem cells such that they have non-functioning channels called gap junctions (GJ). Without GJs, cardiac cells cannot communicate electrically or contract in a coordinated fashion. We will use a variety of lab techniques to confirm that our engineered cells have lost these functions. Second, we will use a pig heart attack model to compare outcomes after the transplantation of normal cardiac cells, our engineered cardiac cells (incapable of synchronous contraction), or placebo. If we find that the normal cells improve heart function (as we have shown in prior work) but that the engineered cells do not, this would provide compelling evidence that the beneficial effects of our cell therapy are direct and are mediated by the formation of electrically integrated new muscle."
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
429159
Name
Pisesky Andrea E
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Evaluating the role of electro-mechanical integration of human pluripotent stem cell-derived cardiomyocyte graft in the treatment of myocardial infarction
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cardiomyocyte; Cell Transplantation; Connexion 43; Electromechanical Integration; Gap Junction; Heart Failure; Human Pluripotent Stem Cell-Derived Cardiomyocytes; Myocardial Infarction; Pluripotent Stem Cells
Abstract
"Heart disease is the leading cause of death worldwide. Because the human heart has a limited capacity to regenerate, stem cell-based therapies have emerged as exciting treatment avenues. We can generate new cardiac cells from stem cells that mediate an improvement in heart function when injected after a heart attack in animal models. It is unclear, however, whether this improvement is due to new, functionally integrated heart muscle or due to indirect effects such as the release of growth factors or improved heart geometry. This mechanistic uncertainty remains a source of controversy in the field, and hampers progress towards clinical trials (as it, for example, remains unclear what cell dose, type and delivery mode are ideal). This project aims to investigate the roles of the direct and indirect mechanisms underpinning the improved heart function observed after injecting new cardiac cells into an infarct scar. First, we will genetically engineer stem cells such that they have non-functioning channels called gap junctions (GJ). Without GJs, cardiac cells cannot communicate electrically or contract in a coordinated fashion. We will use a variety of lab techniques to confirm that our engineered cells have lost these functions. Second, we will use a pig heart attack model to compare outcomes after the transplantation of normal cardiac cells, our engineered cardiac cells (incapable of synchronous contraction), or placebo. If we find that the normal cells improve heart function (as we have shown in prior work) but that the engineered cells do not, this would provide compelling evidence that the beneficial effects of our cell therapy are direct and are mediated by the formation of electrically integrated new muscle."
Competitiondate
201912
Approvedterm2
1 yr 0 mth
Pinamesdelim
Pisesky, Andrea E
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~